Companies / VSee Health, Inc. / Activity
Activity — VSee Health, Inc.
51 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | Leonard Jerry Executive | Grant | Common Stock, par value $0.0001 per share | $0 | +125K | 125,000 0.26% of shares | low |
| Sep 19, 2025 | Leonard Jerry Executive | Grant | Common Stock, par value $0.0001 per share | $0 | +300K +115.06% | 560,724 1.15% of shares | low |
| Sep 19, 2025 | Metzger Scott Director | Grant | Common Stock, par value $0.0001 per share | $524 | +227 +2.63% | 8,852 0.02% of shares | low |
| Sep 19, 2025 | Lowdermilk Kevin Director | Grant | Common Stock, par value $0.0001 per share | $524 | +227 | 227 <0.01% of shares | low |
| Sep 19, 2025 | O'Sullivan Colin P. Director | Grant | Common Stock, par value $0.0001 per share | $524 | +227 | 227 <0.01% of shares | low |
| Sep 19, 2025 | Wickersham David L. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +11K +4.92% | 235,096 0.48% of shares | low |
| Sep 19, 2025 | Metzger Scott Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +11K +58.30% | 29,948 0.06% of shares | low |
| Sep 19, 2025 | Lowdermilk Kevin Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +11K +107.14% | 21,323 0.04% of shares | low |
| Sep 19, 2025 | O'Sullivan Colin P. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +11K +107.14% | 21,323 0.04% of shares | low |
| Sep 19, 2025 | Fairfax Cydonii V. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +11K +109.56% | 21,096 0.04% of shares | low |
| Sep 19, 2025 | Wickersham David L. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +10K +4.70% | 224,067 0.46% of shares | low |
| Sep 19, 2025 | Metzger Scott Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +10K +113.73% | 18,919 0.04% of shares | low |
| Sep 19, 2025 | Lowdermilk Kevin Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +10K +4434.80% | 10,294 0.02% of shares | low |
| Sep 19, 2025 | O'Sullivan Colin P. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +10K +4434.80% | 10,294 0.02% of shares | low |
| Sep 19, 2025 | Fairfax Cydonii V. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +10K | 10,067 0.02% of shares | low |
| Sep 19, 2025 | Wickersham David L. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +13K +5.22% | 260,527 0.54% of shares | low |
| Sep 19, 2025 | Metzger Scott Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +13K +30.46% | 55,379 0.11% of shares | low |
| Sep 19, 2025 | Lowdermilk Kevin Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +13K +38.23% | 46,754 0.10% of shares | low |
| Sep 19, 2025 | O'Sullivan Colin P. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +13K +38.23% | 46,754 0.10% of shares | low |
| Sep 19, 2025 | Fairfax Cydonii V. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +13K +38.49% | 46,527 0.10% of shares | low |
| Sep 19, 2025 | Wickersham David L. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +13K +5.32% | 247,596 0.51% of shares | low |
| Sep 19, 2025 | Metzger Scott Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +13K +41.74% | 42,448 0.09% of shares | low |
| Sep 19, 2025 | Lowdermilk Kevin Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +13K +58.62% | 33,823 0.07% of shares | low |
| Sep 19, 2025 | O'Sullivan Colin P. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +13K +58.62% | 33,823 0.07% of shares | low |
| Sep 19, 2025 | Fairfax Cydonii V. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +13K +59.25% | 33,596 0.07% of shares | low |
| Mar 4, 2026 | O'Sullivan Colin P. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +40K +58.44% | 108,731 0.22% of shares | low |
| Mar 4, 2026 | Metzger Scott Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +40K +51.92% | 117,356 0.24% of shares | low |
| Mar 4, 2026 | Lowdermilk Kevin Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +40K +58.44% | 108,731 0.22% of shares | low |
| Mar 4, 2026 | Wickersham David L. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +40K +3.50% | 1,187,671 2.44% of shares | low |
| Mar 4, 2026 | Fairfax Cydonii V. Director | Grant | Common Stock, par value $0.0001 per share | $15.0K | +40K +58.64% | 108,504 0.22% of shares | low |
| Sep 19, 2025 | Wickersham David L. Director | Grant | Common Stock, par value $0.0001 per share | $15.1K | +22K +8.39% | 282,397 0.58% of shares | low |
| Sep 19, 2025 | Metzger Scott Director | Grant | Common Stock, par value $0.0001 per share | $15.1K | +22K +39.49% | 77,249 0.16% of shares | low |
| Sep 19, 2025 | Lowdermilk Kevin Director | Grant | Common Stock, par value $0.0001 per share | $15.1K | +22K +46.78% | 68,624 0.14% of shares | low |
| Sep 19, 2025 | O'Sullivan Colin P. Director | Grant | Common Stock, par value $0.0001 per share | $15.1K | +22K +46.78% | 68,624 0.14% of shares | low |
| Sep 19, 2025 | Fairfax Cydonii V. Director | Grant | Common Stock, par value $0.0001 per share | $15.1K | +22K +47.01% | 68,397 0.14% of shares | low |
| Mar 23, 2026 | Leonard Jerry Executive | Grant | Common Stock, par value $0.0001 per share | $24.7K | +67K +10.38% | 710,938 1.46% of shares | low |
| Mar 23, 2026 | Leonard Jerry Executive | Grant | Common Stock, par value $0.0001 per share | $25.0K | +21K +3.72% | 581,557 1.20% of shares | low |
| Mar 23, 2026 | Leonard Jerry Executive | Grant | Common Stock, par value $0.0001 per share | $25.0K | +41K +6.80% | 644,093 1.33% of shares | low |
| Mar 23, 2026 | Leonard Jerry Executive | Grant | Common Stock, par value $0.0001 per share | $25.0K | +22K +3.71% | 603,109 1.24% of shares | low |
| Mar 23, 2026 | Aisiku Imoigele CEO | Grant | Common Stock, par value $0.0001 per share | $47.5K | +128K +3.76% | 3,545,031 7.29% of shares | low |
| Mar 23, 2026 | Aisiku Imoigele CEO | Grant | Common Stock, par value $0.0001 per share | $48.0K | +41K +1.26% | 3,338,000 6.87% of shares | low |
| Mar 23, 2026 | Aisiku Imoigele CEO | Grant | Common Stock, par value $0.0001 per share | $48.0K | +40K +1.23% | 3,296,621 6.78% of shares | low |
| Mar 23, 2026 | Aisiku Imoigele CEO | Grant | Common Stock, par value $0.0001 per share | $48.0K | +79K +2.36% | 3,416,689 7.03% of shares | low |
| Aug 15, 2025 | Aisiku Imoigele CEO | Other | Common Stock, par value $0.0001 per share | $50.0K | -25K -0.76% | 3,256,621 6.70% of shares | low |
| Feb 23, 2026 | Wickersham David L. Director | Other | Common Stock, par value $0.0001 per share | $68.4K | +105K +37.27% | 387,648 0.80% of shares | low |
| Aug 14, 2025 | Wickersham David L. Director | Other | Common Stock, par value $0.0001 per share | $200.0K | +100K +87.72% | 214,000 0.44% of shares | low |
| Aug 14, 2025 | Aisiku Imoigele CEO | Other | Common Stock, par value $0.0001 per share | $200.0K | -100K -2.96% | 3,281,621 6.75% of shares | low |
| Feb 23, 2026 | Wickersham David L. Director | Other | Common Stock, par value $0.0001 per share | $243.2K | +760K +196.03% | 1,147,564 2.36% of shares | low |
| Sep 19, 2025 | Leonard Jerry Executive | Grant | Common Stock, par value $0.0001 per share | $295.9K | +136K +108.58% | 260,724 0.54% of shares | low |
| Feb 23, 2026 | Wickersham David L. Director | Other | Convertible Promissory Note | — | — | 0 0.00% of shares | low |